Rinaldetti相关文献与解析，生知库 | 链接生命科学的每一步

Hehlmann, Rüdiger; Voskanyan, Astghik; Lauseker, Michael; Pfirrmann, Markus; Kalmanti, Lida; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Haferlach, Claudia; Schlegelberger, Brigitte; Fabarius, Alice; Seifarth, Wolfgang; Spieß, Birgit; Wuchter, Patrick; Krause, Stefan; Kolb, Hans-Jochem; Neubauer, Andreas; Hossfeld, Dieter K; Nerl, Christoph; Gratwohl, Alois; Baerlocher, Gabriela M; Burchert, Andreas; Brümmendorf, Tim H; Hasford, Jörg; Hochhaus, Andreas; Saußele, Susanne; Baccarani, Michele

细胞生物学

白血病

粒细胞

发表日期：2020

文献求助收藏

Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

更正：低原始细胞计数下出现高危额外染色体异常预示着慢性粒细胞白血病死亡。

期刊:Leukemia

影响因子:13.4

doi:10.1038/s41375-020-01039-7

First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer

具有针对结直肠癌的临床前活性的首创致癌 CHD1L 抑制剂

期刊:Molecular Cancer Therapeutics

影响因子:5.3

doi:10.1158/1535-7163.MCT-20-0106

Joshua M Abbott, Qiong Zhou, Hector Esquer, Laura Pike, Travis P Broneske, Sébastien Rinaldetti, Adedoyin D Abraham, Dominique A Ramirez, Paul J Lunghofer, Todd M Pitts, Daniel P Regan, Aik Choon Tan, Daniel L Gustafson, Wells A Messersmith, Daniel V LaBarbera

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy

根治性膀胱切除术后FOXA1基因表达在肌层浸润性膀胱癌分子亚型鉴定中的应用

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm9040994

Sikic, Danijel; Eckstein, Markus; Wirtz, Ralph M; Jarczyk, Jonas; Worst, Thomas S; Porubsky, Stefan; Keck, Bastian; Kunath, Frank; Weyerer, Veronika; Breyer, Johannes; Otto, Wolfgang; Rinaldetti, Sebastien; Bolenz, Christian; Hartmann, Arndt; Wullich, Bernd; Erben, Philipp

Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials

分子 BCR-ABL1 监测系统的诊断性能可能会影响慢性粒细胞白血病 (CML) 患者是否被纳入终止试验。

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0214305

Spiess, Birgit; Rinaldetti, Sébastien; Naumann, Nicole; Galuschek, Norbert; Kossak-Roth, Ute; Wuchter, Patrick; Tarnopolscaia, Irina; Rose, Diana; Voskanyan, Astghik; Fabarius, Alice; Hofmann, Wolf-Karsten; Saußele, Susanne; Seifarth, Wolfgang

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV

确定慢性粒细胞白血病主要分子缓解的治疗目标：随机 CML 研究 IV 的结果

期刊:Leukemia

影响因子:13.4

doi:10.1038/s41375-018-0055-7

Saussele, Susanne; Hehlmann, Rüdiger; Fabarius, Alice; Jeromin, Sabine; Proetel, Ulrike; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Einsele, Hermann; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F; Oppliger Leibundgut, Elisabeth; Heim, Dominik; Krause, Stefan W; Hofmann, Wolf-Karsten; Hasford, Joerg; Pfirrmann, Markus; Müller, Martin C; Hochhaus, Andreas; Lauseker, Michael

FOXM1 predicts disease progression in non-muscle invasive bladder cancer

FOXM1 可预测非肌层浸润性膀胱癌的疾病进展

期刊:Journal of Cancer Research and Clinical Oncology

影响因子:2.8

doi:10.1007/s00432-018-2694-5

Rinaldetti, Sebastien; Wirtz, Ralph; Worst, Thomas Stefan; Hartmann, Arndt; Breyer, Johannes; Dyrskjot, Lars; Erben, Philipp

The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia

质量控制图 (QCC) 对慢性粒细胞白血病常规定量 BCR-ABL1 监测的益处

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0196326

Spiess, Birgit; Naumann, Nicole; Galuschek, Norbert; Rinaldetti, Sébastien; Kossak-Roth, Ute; Tarnopolscaia, Irina; Felde, Elena; Fabarius, Alice; Hofmann, Wolf-Karsten; Saußele, Susanne; Seifarth, Wolfgang

AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer

AST-487抑制膀胱癌中RET激酶驱动的TERT表达

High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes

针对分子膀胱癌亚型的高内涵药物发现

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

低原始细胞计数下出现高危额外染色体异常预示着慢性粒细胞白血病（CML）患者死亡。

Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

更正：低原始细胞计数下出现高危额外染色体异常预示着慢性粒细胞白血病死亡。

First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer

具有针对结直肠癌的临床前活性的首创致癌 CHD1L 抑制剂

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy

根治性膀胱切除术后FOXA1基因表达在肌层浸润性膀胱癌分子亚型鉴定中的应用

Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials

分子 BCR-ABL1 监测系统的诊断性能可能会影响慢性粒细胞白血病 (CML) 患者是否被纳入终止试验。

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV

确定慢性粒细胞白血病主要分子缓解的治疗目标：随机 CML 研究 IV 的结果

FOXM1 predicts disease progression in non-muscle invasive bladder cancer

FOXM1 可预测非肌层浸润性膀胱癌的疾病进展

The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia

质量控制图 (QCC) 对慢性粒细胞白血病常规定量 BCR-ABL1 监测的益处